| scholarly article | Q13442814 |
| P50 | author | Cecília Rodrigues | Q30421070 |
| Rui E. Castro | Q43087499 | ||
| P2093 | author name string | A Costa | |
| T Evangelista | |||
| J Coutinho | |||
| A Silvestre | |||
| D M S Ferreira | |||
| F Carepa | |||
| H Cortez-Pinto | |||
| M V Machado | |||
| P2860 | cites work | Nonalcoholic fatty liver disease: a feature of the metabolic syndrome | Q28208772 |
| High fat feeding and dietary L-arginine supplementation differentially regulate gene expression in rat white adipose tissue | Q28569883 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance | Q29619774 | ||
| Prevention of steatosis by hepatic JNK1 | Q33580974 | ||
| Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects | Q34218011 | ||
| Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance | Q34708975 | ||
| Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | Q35115696 | ||
| Caspase-2 deficiency enhances aging-related traits in mice | Q35688389 | ||
| Apoptosis in alcoholic and nonalcoholic steatohepatitis | Q36170407 | ||
| Insulin resistance: a metabolic pathway to chronic liver disease | Q36297331 | ||
| Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice | Q36519843 | ||
| Pathophysiology of insulin resistance. | Q36679888 | ||
| Insulin sensitivity: modulation by nutrients and inflammation | Q36848937 | ||
| Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance | Q37038490 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| Phosphorylation of IRS proteins, insulin action, and insulin resistance | Q37252616 | ||
| Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease | Q37310283 | ||
| Diabetes and apoptosis: lipotoxicity | Q37473207 | ||
| Diabetes and apoptosis: liver | Q37526657 | ||
| Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation | Q37580452 | ||
| The unpredictable caspase-2: what can it do? | Q37671358 | ||
| Insulin resistance, adipose depots and gut: interactions and pathological implications | Q37701066 | ||
| From the metabolic syndrome to NAFLD or vice versa? | Q37703968 | ||
| Comparison of the effect of individual saturated and unsaturated fatty acids on cell growth and death induction in the human pancreatic beta-cell line NES2Y. | Q40013622 | ||
| A stress signaling pathway in adipose tissue regulates hepatic insulin resistance | Q41811449 | ||
| Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax | Q42155537 | ||
| Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells. | Q42573914 | ||
| Modulation of amyloid-β peptide-induced toxicity through inhibition of JNK nuclear localization and caspase-2 activation. | Q42905339 | ||
| Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism | Q44666291 | ||
| Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease | Q44934521 | ||
| Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway | Q44967749 | ||
| Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms | Q45300618 | ||
| Dose-response effect of elevated plasma free fatty acid on insulin signaling | Q46513253 | ||
| Molecular determinants of insulin resistance, cell apoptosis and lipid accumulation in non-alcoholic steatohepatitis. | Q46863162 | ||
| JNK1 but not JNK2 promotes the development of steatohepatitis in mice | Q46865809 | ||
| Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha | Q47586381 | ||
| Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice | Q48630964 | ||
| beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation | Q48932916 | ||
| Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR:LA-cp rats. | Q51438855 | ||
| Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. | Q51466405 | ||
| Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. | Q51580928 | ||
| Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. | Q54691032 | ||
| Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis | Q57760188 | ||
| Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients | Q57760193 | ||
| Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects | Q60462188 | ||
| Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis | Q73735584 | ||
| Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis | Q82677113 | ||
| P433 | issue | 7 | |
| P921 | main subject | patient | Q181600 |
| insulin resistance | Q1053470 | ||
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| preproinsulin | Q7240673 | ||
| non-alcoholic fatty liver | Q66299798 | ||
| P304 | page(s) | 1788-1798 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. | |
| P478 | volume | 54 |
| Q48242025 | Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis. |
| Q30620446 | Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling |
| Q55503094 | Apoptosis and non-alcoholic fatty liver diseases. |
| Q38098902 | Apoptotic pathways in adipose tissue |
| Q89909412 | Atorvastatin promotes AMPK signaling to protect against high fat diet-induced non-alcoholic fatty liver in golden hamsters |
| Q42517446 | Caspase-2 deficiency enhances whole-body carbohydrate utilisation and prevents high-fat diet-induced obesity |
| Q53685192 | Caspases in metabolic disease and their therapeutic potential. |
| Q59449558 | Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance |
| Q64110486 | Changes of Th17/Treg ratio in the transition of chronic hepatitis B to liver cirrhosis and correlations with liver function and inflammation |
| Q26767346 | Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma |
| Q91732484 | Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease |
| Q51225674 | Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis. |
| Q36795583 | Distinct functions of JNK and c-Jun in oxidant-induced hepatocyte death |
| Q39095568 | Effect of curcumin on visfatin and zinc-α2-glycoprotein in a rat model of non-alcoholic fatty liver disease |
| Q33786900 | Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro. |
| Q38028344 | Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus |
| Q90047443 | Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis |
| Q43951595 | Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. |
| Q61829305 | Increased expression of c-Jun in nonalcoholic fatty liver disease |
| Q36333430 | Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis. |
| Q36588248 | Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects |
| Q34168368 | Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. |
| Q36477235 | Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis |
| Q34501819 | Mechanism of the promotion of steatotic HepG2 cell apoptosis by cholesterol |
| Q42123455 | Melatonin in the regulation of liver steatosis following prenatal glucocorticoid exposure. |
| Q89761376 | Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer |
| Q47413881 | Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism |
| Q35931190 | NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. |
| Q38202220 | Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. |
| Q39002205 | Saturated free fatty acids induce cholangiocyte lipoapoptosis. |
| Q55339592 | The effect of aging on mitochondrial and cytosolic hepatic intrinsic death pathway and apoptosis associated proteins in Fischer 344 rats. |
| Q86346297 | What it means to receive the UEG Rising Star Award |
| Q37643931 | c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. |
| Q33815927 | miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice |
Search more.